Iradimed Corp (NASDAQ:IRMD) VP Sells $65,670.00 in Stock

Iradimed Corp (NASDAQ:IRMD) VP Brent Johnson sold 3,000 shares of Iradimed stock in a transaction on Monday, September 16th. The shares were sold at an average price of $21.89, for a total transaction of $65,670.00. Following the completion of the sale, the vice president now directly owns 4,368 shares of the company’s stock, valued at approximately $95,615.52. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website.

Brent Johnson also recently made the following trade(s):

  • On Thursday, September 12th, Brent Johnson sold 1,000 shares of Iradimed stock. The stock was sold at an average price of $20.25, for a total transaction of $20,250.00.
  • On Tuesday, September 10th, Brent Johnson sold 1,000 shares of Iradimed stock. The stock was sold at an average price of $20.00, for a total transaction of $20,000.00.
  • On Wednesday, August 21st, Brent Johnson sold 1,000 shares of Iradimed stock. The stock was sold at an average price of $20.62, for a total transaction of $20,620.00.
  • On Monday, August 19th, Brent Johnson sold 1,000 shares of Iradimed stock. The stock was sold at an average price of $21.21, for a total transaction of $21,210.00.
  • On Friday, August 16th, Brent Johnson sold 2,000 shares of Iradimed stock. The stock was sold at an average price of $20.92, for a total transaction of $41,840.00.
  • On Wednesday, August 14th, Brent Johnson sold 1,000 shares of Iradimed stock. The stock was sold at an average price of $21.10, for a total transaction of $21,100.00.
  • On Monday, August 12th, Brent Johnson sold 1,000 shares of Iradimed stock. The stock was sold at an average price of $21.27, for a total transaction of $21,270.00.
  • On Friday, August 9th, Brent Johnson sold 2,400 shares of Iradimed stock. The stock was sold at an average price of $21.81, for a total transaction of $52,344.00.
  • On Monday, August 5th, Brent Johnson sold 3,000 shares of Iradimed stock. The stock was sold at an average price of $21.94, for a total transaction of $65,820.00.
  • On Wednesday, August 7th, Brent Johnson sold 7,000 shares of Iradimed stock. The stock was sold at an average price of $21.93, for a total transaction of $153,510.00.

IRMD traded down $0.78 during mid-day trading on Tuesday, reaching $22.31. 41,300 shares of the stock were exchanged, compared to its average volume of 68,562. The company has a debt-to-equity ratio of 0.06, a quick ratio of 9.39 and a current ratio of 10.29. The stock has a market capitalization of $261.95 million, a PE ratio of 51.88 and a beta of 1.67. The company has a 50 day moving average price of $20.74 and a two-hundred day moving average price of $22.59. Iradimed Corp has a 1 year low of $16.68 and a 1 year high of $38.78.

Iradimed (NASDAQ:IRMD) last posted its quarterly earnings data on Tuesday, July 30th. The medical equipment provider reported $0.17 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $0.12 by $0.05. The firm had revenue of $9.23 million for the quarter, compared to the consensus estimate of $8.91 million. Iradimed had a net margin of 23.92% and a return on equity of 14.78%. Sell-side analysts expect that Iradimed Corp will post 0.67 EPS for the current fiscal year.

IRMD has been the topic of a number of analyst reports. ValuEngine raised shares of Iradimed from a “sell” rating to a “hold” rating in a report on Wednesday, July 31st. Zacks Investment Research downgraded shares of Iradimed from a “buy” rating to a “hold” rating in a report on Wednesday, July 3rd.

Several large investors have recently modified their holdings of IRMD. Bank of America Corp DE boosted its holdings in shares of Iradimed by 24.8% in the 4th quarter. Bank of America Corp DE now owns 19,532 shares of the medical equipment provider’s stock worth $477,000 after buying an additional 3,882 shares during the last quarter. Victory Capital Management Inc. purchased a new position in shares of Iradimed in the 1st quarter worth about $212,000. Spark Investment Management LLC boosted its holdings in shares of Iradimed by 86.4% in the 1st quarter. Spark Investment Management LLC now owns 56,100 shares of the medical equipment provider’s stock worth $1,575,000 after buying an additional 26,000 shares during the last quarter. Acadian Asset Management LLC boosted its holdings in shares of Iradimed by 10.9% in the 1st quarter. Acadian Asset Management LLC now owns 29,764 shares of the medical equipment provider’s stock worth $836,000 after buying an additional 2,920 shares during the last quarter. Finally, Fiera Capital Corp purchased a new position in shares of Iradimed in the 1st quarter worth about $1,442,000. 30.33% of the stock is currently owned by institutional investors.

About Iradimed

IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible medical devices, and related accessories and services in the United States and internationally. It offers MRI compatible intravenous (IV) infusion pump system with associated disposable IV tubing sets; and MRI compatible patient vital signs monitoring system.

Featured Story: Why is the ex-dividend date different from the record date?

Insider Buying and Selling by Quarter for Iradimed (NASDAQ:IRMD)

Receive News & Ratings for Iradimed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Iradimed and related companies with MarketBeat.com's FREE daily email newsletter.